HELX vs WDNA: Holdings Overlap & Returns

Over the year to Nov 13, 2026, HELX returned +22.6% to WDNA's +43.3%; 33% of their weight is in the same names.

Return gap
+20.7 pts1 year to Nov 13, 2026: WDNA ahead, total return
Fee gap
0.05 ptsA year: HELX 0.50%, WDNA 0.45%, per filings dated Jul 27, 2026 and Oct 28, 2026
Overlap
33%Share of the two books held in common, holdings dated Jun 30, 2026
Net flow
–Needs daily flows for both funds
The answerOne drawing that carries it.

Compare two other funds

The evidenceWhy, in charts and cards.
HELX and WDNA · 1 year

Growth of 100

HELX +22.6%WDNA +43.3%
Growth of 100 in HELX and WDNA over 1 year, Nov 13, 2025 to Nov 13, 2026, with distributions reinvested. HELX ends at 122.6 (+22.6%), WDNA at 143.3 (+43.3%).

HELX +22.6%, WDNA +43.3%: WDNA +20.7 pts ahead, 1 year, Nov 13, 2025 to Nov 13, 2026.

Share

Use this comparison

Alert

The week's ETF fund flows, by email on Sundays.

One-click unsubscribe. See Privacy.

Hypothetical · drag to set

Fees over time

Hypothetical. $10,000 in HELX for 10 years at 0.50% a year costs about $827 in fees and lost growth; WDNA at 0.45% would cost $746. Assumes 6% a year before fees, a sample rate, not a forecast.

How each fund moved

HELX · 1 year to Nov 13, 202685% of its weight is outside the S&P 500
85% of its weight is outside the S&P 50015% of HELX's weight is in S&P 500 companies and 85% is outside the index. Holdings as of Jun 30, 2026.15%85%in the S&P 500of its weight outside the S&P 500active share 97% · top ten 47% of the fund · 61 holdings as filed for Jun 30, 2026 · Nasdaq-100: 8% in85% of its weight is outside the S&P 50015% of HELX's weight is in S&P 500 companies and 85% is outside the index. Holdings as of Jun 30, 2026.15%85%inof its weight outside the S&P 500active share 97% · Nasdaq-100: 8% in

15% of HELX's weight is in S&P 500 companies and 85% is outside the index. Holdings as of Jun 30, 2026.

WDNA · 1 year to Nov 13, 202674% of its weight is outside the S&P 500
74% of its weight is outside the S&P 50026% of WDNA's weight is in S&P 500 companies and 74% is outside the index. Holdings as of Jun 30, 2026.26%74%in the S&P 500of its weight outside the S&P 500active share 95% · top ten 31% of the fund · 80 holdings as filed for Jun 30, 2026 · Nasdaq-100: 5% in74% of its weight is outside the S&P 50026% of WDNA's weight is in S&P 500 companies and 74% is outside the index. Holdings as of Jun 30, 2026.26%74%inoutside the S&P 500active share 95% · Nasdaq-100: 5% in

26% of WDNA's weight is in S&P 500 companies and 74% is outside the index. Holdings as of Jun 30, 2026.

Key numbers

HELX in the S&P 500
14.9%
WDNA in the S&P 500
25.9%
HELX total return, 1 year
+22.6%
WDNA total return, 1 year
+43.3%

WDNA costs 0.05 points a year less; their one-year returns differ by 20.7 points.

Pair scorecard

Open the table

Points (pts) are percentage points.

Total return, 1 year+22.6%+43.3%
Below its all-time high26.5%, high on Sep 7, 202113.9%, high on Sep 2, 2021
What it tracksHealthcare innovation and GLP-1Healthcare innovation and GLP-1
Expense ratio0.50%0.45%
Net assets, HELX as of Nov 12, 2026 and WDNA as of Jun 30, 2026$34m$2.7m
Holdings in common33%

The numbers behind it

Net assets: $34m on Nov 12, 2026 for Franklin Genomic Advancements ETF, and $2.7m on Jun 30, 2026 for WisdomTree BioRevolution Fund.

Holdings in common uses holdings dated Jun 30, 2026.

What they share

By the books each fund has filed, HELX and WDNA hold 33% of their money in the same securities at the same weight. Holdings dated Jun 30, 2026.

0half (50%)100%

half

33% in common

Held in common

Show all 12 holdings
ELI LILLY & COMPANY2.95%4.08%
TWIST BIOSCIENCE CORP2.85%5.95%
UNITED THERAPEUTICS CORP3.51%2.45%
NATERA INC7.46%2.32%
CORTEVA INC2.25%1.99%
KRYSTAL BIOTECH INC6.33%1.96%
TEMPUS AI INC1.95%2.28%
IONIS PHARMACEUTICALS INC1.91%1.86%
ASTRAZENECA PLC2.70%1.83%
VERACYTE INC1.64%1.46%
VERTEX PHARMACEUTICALS INC2.75%1.34%
STOKE THERAPEUTICS INC1.33%2.09%

Only in HELX

Show all 8 holdings
GUARDANT HEALTH INC9.09%
LIGAND PHARMACEUTICALS INC4.62%
ADAPTIVE BIOTECHNOLOGIES CORP3.99%
TRAVERE THERAPEUTICS INC2.59%
SAMSUNG BIOLOGICS CO LTD2.26%
MEDPACE HOLDINGS INC2.15%
NEUROCRINE BIOSCIENCES INC1.84%
ARGENX SE1.64%

Only in WDNA

Show all 8 holdings
MODERNA INC4.14%
JOHNSON & JOHNSON2.97%
IMMUNOME INC2.26%
STRUCTURE THERAPEUTICS INC2.12%
DARLING INGREDIENTS INC1.94%
10X GENOMICS INC1.81%
ROIVANT SCIENCES LTD1.73%
ABSCI CORP1.71%

Side by side

Open the table
FundFranklin Genomic Advancements ETF · Holds 61 stocks in healthcare innovation and GLP-1, 15% of its weight in S&P 500 companiesWisdomTree BioRevolution Fund · Holds 80 stocks in healthcare innovation and GLP-1, 26% of its weight in S&P 500 companies
IssuerFranklinWisdomTree
ThemeHealthcare innovation and GLP-1Healthcare innovation and GLP-1
In the S&P 50014.9%25.9%
Active share vs the S&P 50097.2%95.3%
In the Nasdaq-1007.5%5.2%
Holdings6180
Top ten, share of the fund47.1%30.7%
Expense ratio0.50%0.45%
Fee for the differing part0.51%0.47%
Total return, 1 year+22.6%+43.3%
vs its benchmarknot measurednot measured
Below its high−26.5%−13.9%
Net assets, HELX as of Nov 12, 2026 and WDNA as of Jun 30, 2026$34m$2.7m

As of Nov 13, 2026. Source: ETFIQ.

Window by window

Open the table
3 months+5.0%+6.8%
6 months+29.7%+30.6%
1 year+22.6%+43.3%
3 years+57.1%+62.5%
Since launch (Not the same days: HELX Feb 2020 · WDNA Jun 2021)+78.8%−3.7%

About HELX

By weight, 15% of HELX's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 97%. The top ten holdings are 47% of the fund across 61 positions, as filed for Jun 30, 2026.

More

Over the year to Nov 13, 2026 the fund returned +22.6% with distributions reinvested. It sits 26.5% below its all-time high of Sep 7, 2021.

About WDNA

By weight, 26% of WDNA's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 95%. The top ten holdings are 31% of the fund across 80 positions, as filed for Jun 30, 2026.

More

Over the year to Nov 13, 2026 the fund returned +43.3% with distributions reinvested. It sits 13.9% below its all-time high of Sep 2, 2021.

33% of the two portfolios are the same securities at the same weight.

Questions people ask

Do HELX and WDNA hold the same stocks?

By their latest filings, 33% of their books are the same securities at the same weight. Overlap is the sum of the smaller weight of every security they share.

Which is more different from the S&P 500, HELX or WDNA?

HELX has 15% of its weight in S&P 500 names and WDNA has 26%, so HELX differs more from the index.

Which is cheaper, HELX or WDNA?

HELX charges 0.50% a year and WDNA charges 0.45%, so WDNA is cheaper. Fees come from each fund's prospectus.

Other comparisons

Sources

More

Links are sources, not endorsements. A comparison is not a recommendation.

Copy and cite

Cite this pageCitation, APA and Markdown

ETFIQ, HELX against WDNA, data as of Nov 13, 2026. https://etfiq.com/compare/themes/helx-vs-wdna

Open data

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.